The new fight over abortion pills

Fears of impending AI doom have burst into the mainstream. They still might not be enough for Washington to regulate AI. This episode was produced by Kelli Wessinger and Hady Mawajdeh, edited by Jolie Myers, fact checked by Danielle Hewitt and Peter Balonon-Rosen, engineered by D ...  Show more

Republicans are stoking anti-Muslim sentiment in new ways ahead of the midterms. This episode was produced by Avishay Artsy and Danielle Hewitt, edited by Amina Al-Sadi, fact-checked by Peter Balonon-Rosen and Ariana Aspuru, engineered by Bridger Dunnagan and David Tatasciore, an ...  Show more

In 2000, the F.D.A. approved the medication abortion drug mifepristone. Now a federal judge in Texas is set to rule on a case filed by anti-abortion groups urging the agency to revoke its approval of mifepristone and the other main drug used for medication abortion in the Unit ...

Today on Post Reports, we take you to an abortion hearing in Amarillo, Tex., that the judge didn’t want you to know was coming. 

Read more:

In a four-hour hearing on Wednesday, U.S. District Judge Matthew Kacsmaryk heard arguments in

A Fifth Circuit ruling that keeps mifepristone available, but curtails access to it, is the newest front in a battle over the FDA’s power to approve medications. Read the story here. Learn more about your ad choices. Visit podcastchoices.com/adchoices 

Abortion pills — a combo of two drugs, mifepristone and misoprostol — are on notice: on April 7, 2023, a federal judge said the FDA’s approval of mifepristone was invalid. And then, not more than an hour later, another federal judge in a separate case said that mifepristone ha ...